CBD Diamonds are produced using specialized secondary crystallization techniques that drive supersaturated liquid cannabinoid solutions into large, solid crystalline lattices. Initial extraction of GACP-compliant Cannabis sativa L. biomass is conducted via sub-zero cryogenic ethanol or supercritical CO₂, followed by rigorous winterization and secondary fractional distillation to concentrate raw cannabidiol.
The resulting high-purity distillate is introduced into specialized crystallization bioreactors under controlled temperature ramp-downs, precise solvent-antisolvent dynamics, and steady atmospheric pressure. Over a 14 to 28-day crystallization window, cannabidiol molecules spontaneously nucleate and assemble into dense, translucent, diamond-like geometric prisms. The crystallized matrix is then separated, subjected to vacuum purge desiccation to remove all traces of volatile processing solvents, and categorized by particle dimension. The final product provides clinical prescribers and licensed compounding pharmacists with a consistent, non-intoxicating active pharmaceutical ingredient.
Technical Specifications & Certificate of Analysis (CoA)
Sensory & Crystalline Morphology Breakdown
-
Macroscopic Crystalline Architecture: Dense, jagged, semi-translucent stones ranging from 3 mm to 15 mm in individual diameter, exhibiting clean cleavage planes and high refractive clarity.
-
Neutral Organoleptic Profile: In its isolated crystalline state, the compound is virtually odorless and flavorless, ensuring complete formulation neutrality in clinical oils or seamless pairing with strain-specific terpene sauces.
-
Vaporization & Compounding Rheology: Melts cleanly at 66°C–69°C into an ultra-low viscosity fluid with zero carbonaceous residue, eliminating harsh throat friction during thermal vaporization and allowing rapid dissolution into pharmaceutical MCT, olive, or hemp seed carrier oils.
European Compliance, Quality Assurance & Distribution
-
EU-GMP Part II Active Pharmaceutical Ingredient (API): Synthesized and harvested under strict cleanroom conditions compliant with EU-GMP Part II standards for active pharmaceutical substances, guaranteeing complete process validation, batch trace-forward tracking, and prevention of cross-contamination.
-
Non-Controlled Legal Status Across the EU: With verified THC concentrations below 0.01% (and non-detectable via standard HPLC-DAD/MS detection), CBD Diamonds operate outside standard narcotics scheduling across Germany, Austria, France, Italy, and greater Schengen territories, allowing simplified commercial customs clearance.
-
Accredited Laboratory Verification: Every production batch is accompanied by comprehensive third-party ISO/IEC 17025 accredited Certificates of Analysis (CoAs) verifying cannabinoid potency, complete absence of residual crystallization solvents (pentane, heptane, ethanol), heavy metals, agrochemicals, and foreign matter.
-
Hermetic Pharmaceutical Containment: Supplied in medical-grade borosilicate glass jars or pharmaceutical-grade high-density polyethylene (HDPE) bulk containers with induction-sealed tamper-evident liners and desiccant sachets to prevent atmospheric moisture absorption and maintain crystalline stability.
Product Tags




